Skip to main content
SpringerLink
Log in

Toxicity Management for Pelvic Tumors in Radiation Oncology

  • Chapter
  • First Online:
Prevention and Management of Acute and Late Toxicities in Radiation Oncology

  • 701 Accesses

Abstract

Radiation therapy (RT) is used widely for the treatment of pelvic tumors. The protection of organs at risk (OAR) in the pelvis is crucial in cancer survivors. This chapter will outline the pathophysiology of radiation-induced pelvic toxicity, biologic and clinical principles of pelvic tolerance to radiation, and the treatment strategies of both acute and chronic radiation-induced pelvic toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Viana R, Batourina E, Huang H, et al. The development of the bladder trigone, the center of the anti-reflux mechanism. Development. 2007;134:3763–9.

    Article  CAS  PubMed  Google Scholar 

  2. Sica GT, Teeger S. MR imaging of scrotal, testicular, and penile diseases. Magn Reson Imaging Clin N Am. 1996;4:545–63.

    CAS  PubMed  Google Scholar 

  3. Roach M 3rd, Nam J, Gagliardi G, et al. Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys. 2010;76:S130–4.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sala EJ, Atri M. Magnetic resonance imaging of benign adnexal disease. Top Magn Reson Imaging. 2003;14:305–27.

    Article  PubMed  Google Scholar 

  5. Gay HA, Barthold HJ, O’Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83:e353–62.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ranieri G, Patruno R, Ruggieri E, et al. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem. 2006;13:1845–57.

    Article  CAS  PubMed  Google Scholar 

  7. Jain RK, Duda DG, Clark JW, Loeffler JS. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol. 2006;3:24–40.

    Article  CAS  PubMed  Google Scholar 

  8. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rancoule C, Guy JB, Vallard A, et al. 50th anniversary of cisplatin. Bull Cancer. 2017;104:167–76.

    Article  PubMed  Google Scholar 

  10. Xue R, Cai X, Xu H, et al. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis. Gynecol Oncol. 2018;150:412–9.

    Article  CAS  PubMed  Google Scholar 

  11. Zagouri F, Korakiti AM, Zakopoulou R, et al. Taxanes during pregnancy in cervical cancer: a systematic review and pooled analysis. Cancer Treat Rev. 2019;79:101885.

    Article  PubMed  CAS  Google Scholar 

  12. Viswanathan AN, Moughan J, Miller BE, et al. NRG Oncology/RTOG 0921: a phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. 2015;121:2156–63.

    Article  CAS  PubMed  Google Scholar 

  13. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.

    Article  PubMed  Google Scholar 

  14. Frazzoni L, La Marca M, Guido A, et al. Pelvic radiation disease: updates on treatment options. World J Clin Oncol. 2015;6:272–80.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol. 2010;11:310–2.

    Article  PubMed  Google Scholar 

  16. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353:267–72.

    Article  CAS  PubMed  Google Scholar 

  17. Atwood KC, Norman A. On the interpretation of multi-hit survival curves. Proc Natl Acad Sci U S A. 1949;35:696–709.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy--pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11:470–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Morris KA, Haboubi NY. Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg. 2015;7:279–88.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Matta R, Chapple CR, Fisch M, et al. Pelvic complications after prostate Cancer radiation therapy and their management: an international collaborative narrative review. Eur Urol. 2019;75:464–76.

    Article  PubMed  Google Scholar 

  21. Yarnold J. Molecular aspects of cellular responses to radiotherapy. Radiother Oncol. 1997;44:1–7.

    Article  CAS  PubMed  Google Scholar 

  22. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 2013;23:12–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:928–42.

    Article  PubMed  Google Scholar 

  24. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–9.

    Article  PubMed  Google Scholar 

  25. Nicholas S, Chen L, Choflet A, et al. Pelvic radiation and normal tissue toxicity. Semin Radiat Oncol. 2017;27:358–69.

    Article  PubMed  Google Scholar 

  26. McBride SM, Wong DS, Dombrowski JJ, et al. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer. 2012;118:3681–90.

    Article  PubMed  Google Scholar 

  27. Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1438–44.

    Article  CAS  PubMed  Google Scholar 

  28. Sharma NK, Li T, Chen DY, et al. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2011;80:437–44.

    Article  PubMed  Google Scholar 

  29. Kwak YK, Lee SW, Kay CS, Park HH. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose. PLoS One. 2017;12:e0183339.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Vanneste BG, Van De Voorde L, de Ridder RJ, et al. Chronic radiation proctitis: tricks to prevent and treat. Int J Color Dis. 2015;30:1293–303.

    Article  Google Scholar 

  31. Denton AS, Andreyev HJ, Forbes A, Maher EJ. Systematic review for non-surgical interventions for the management of late radiation proctitis. Br J Cancer. 2002;87:134–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pan YB, Maeda Y, Wilson A, et al. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review. Acta Oncol. 2018;57:1427–37.

    Article  PubMed  Google Scholar 

  33. Lindgren A, Dunberger G, Steineck G et al. Identifying female pelvic cancer survivors with low levels of physical activity after radiotherapy: women with fecal and urinary leakage need additional support. Support Care Cancer. 2019. https://doi.org/10.1007/s00520-019-05033-3.

  34. Choi KH, Kim JY, Lee DS, et al. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy. Medicine (Baltimore). 2018;97:e0517.

    Article  Google Scholar 

  35. Willett CG, Ooi CJ, Zietman AL, et al. Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. Int J Radiat Oncol Biol Phys. 2000;46:995–8.

    Article  CAS  PubMed  Google Scholar 

  36. Viswanathan AN, Yorke ED, Marks LB, et al. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76:S116–22.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Grun A, Kawgan-Kagan M, Kaul D, et al. Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer. Strahlenther Onkol. 2019;195:517–25.

    Article  PubMed  Google Scholar 

  38. Brand DH, Tree AC, Ostler P, et al. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2019;20:1531.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and Para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51:261–6.

    Article  CAS  PubMed  Google Scholar 

  41. Wang W, Hou X, Yan J, et al. Outcome and toxicity of radical radiotherapy or concurrent chemoradiotherapy for elderly cervical cancer women. BMC Cancer. 2017;17:510.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Kim S, Moore DF, Shih W, et al. Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last? J Urol. 2013;189:116–21.

    Article  PubMed  Google Scholar 

  43. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995;75:836–43.

    Article  CAS  PubMed  Google Scholar 

  44. Mallick S, Madan R, Julka PK, Rath GK. Radiation induced cystitis and proctitis - prediction, assessment and management. Asian Pac J Cancer Prev. 2015;16:5589–94.

    Article  PubMed  Google Scholar 

  45. Prasad KN, Pradhan S, Datta NR. Urinary tract infection in patients of gynecological malignancies undergoing external pelvic radiotherapy. Gynecol Oncol. 1995;57:380–2.

    Article  CAS  PubMed  Google Scholar 

  46. Levenback C, Eifel PJ, Burke TW, et al. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55:206–10.

    Article  CAS  PubMed  Google Scholar 

  47. Lawton CA, Bae K, Pilepich M, et al. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. Int J Radiat Oncol Biol Phys. 2008;70:437–41.

    Article  CAS  PubMed  Google Scholar 

  48. Montana GS, Fowler WC. Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys. 1989;16:95–100.

    Article  CAS  PubMed  Google Scholar 

  49. Georgiou A, Grigsby PW, Perez CA. Radiation induced lumbosacral plexopathy in gynecologic tumors: clinical findings and dosimetric analysis. Int J Radiat Oncol Biol Phys. 1993;26:479–82.

    Article  CAS  PubMed  Google Scholar 

  50. Klimek M, Kosobucki R, Luczyńska E, et al. Radiotherapy-induced lumbosacral plexopathy in a patient with cervical cancer: a case report and literature review. Contemp Oncol (Pozn). 2012;16:194–6.

    Google Scholar 

  51. Henry AP, Lachmann E, Tunkel RS, Nagler W. Pelvic insufficiency fractures after irradiation: diagnosis, management, and rehabilitation. Arch Phys Med Rehabil. 1996;77:414–6.

    Article  CAS  PubMed  Google Scholar 

  52. Park SH, Kim JC, Lee JE, Park IK. Pelvic insufficiency fracture after radiotherapy in patients with cervical cancer in the era of PET/CT. Radiation Oncol J. 2011;29:269–76.

    Article  PubMed Central  Google Scholar 

  53. Grigsby PW, Roberts HL, Perez CA. Femoral neck fracture following groin irradiation. Int J Radiat Oncol Biol Phys. 1995;32:63–7.

    Article  CAS  PubMed  Google Scholar 

  54. Igdem S, Alco G, Ercan T, et al. Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2010;77:818–23.

    Article  PubMed  Google Scholar 

  55. Quick AM, Seamon LG, Abdel-Rasoul M, et al. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma. Int J Gynecol Cancer. 2012;22:703–8.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Bruner DW, Lanciano R, Keegan M, et al. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.

    Article  CAS  PubMed  Google Scholar 

  57. Grigsby PW, Russell A, Bruner D, et al. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys. 1995;31:1281–99.

    Article  CAS  PubMed  Google Scholar 

  58. Jensen PT, Froeding LP. Pelvic radiotherapy and sexual function in women. Transl Androl Urol. 2015;4:186–205.

    PubMed  PubMed Central  Google Scholar 

  59. Hofsjo A, Bergmark K, Blomgren B, et al. Radiotherapy for cervical cancer - impact on the vaginal epithelium and sexual function. Acta Oncol. 2018;57:338–45.

    Article  PubMed  Google Scholar 

  60. Zelga P, Tchórzewski M, Zelga M, et al. Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies-new patients, old problem? Langenbeck’s Arch Surg. 2017;402:1079–88.

    Article  Google Scholar 

  61. Perez CA, Camel HM, Galakatos AE, et al. Definitive irradiation in carcinoma of the vagina: long-term evaluation of results. Int J Radiat Oncol Biol Phys. 1988;15:1283–90.

    Article  CAS  PubMed  Google Scholar 

  62. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005;62:138–47.

    Article  PubMed  Google Scholar 

  63. Delishaj D, Barcellini A, D’Amico R, et al. Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results. J Contemp Brachytherapy. 2018;10:559–66.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Stryker JA. Radiotherapy for vaginal carcinoma: a 23-year review. Br J Radiol. 2000;73:1200–5.

    Article  CAS  PubMed  Google Scholar 

  65. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;2005:12–7.

    Article  CAS  Google Scholar 

  66. Mulhall J, Ahmed A, Parker M, Mohideen N. The hemodynamics of erectile dysfunction following external beam radiation for prostate cancer. J Sex Med. 2005;2:432–7.

    Article  PubMed  Google Scholar 

  67. Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol. 2009;27:3916–22.

    Article  PubMed  Google Scholar 

  68. Watkins Bruner D, James JL, Bryan CJ, et al. Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215. J Sex Med. 2011;8:1228–38.

    Article  PubMed  CAS  Google Scholar 

  69. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys. 2000;48:1307–10.

    Article  CAS  PubMed  Google Scholar 

  70. Kouvaris JR, Kouloulias VE, Plataniotis GA, et al. Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen. 2001;9:187–93.

    Article  CAS  PubMed  Google Scholar 

  71. Wei J, Meng L, Hou X, et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res. 2019;11:167–77.

    Article  CAS  PubMed  Google Scholar 

  72. Do NL, Nagle D, Poylin VY. Radiation proctitis: current strategies in management. Gastroenterol Res Pract. 2011;2011:917941.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol. 2013;19:199–208.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993;36:564–72.

    Article  CAS  PubMed  Google Scholar 

  75. Klee M, Thranov I, Machin D. Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol. 2000;76:5–13.

    Article  CAS  PubMed  Google Scholar 

  76. Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16:288–93.

    Article  CAS  PubMed  Google Scholar 

  77. Stacey R, Green JT. Radiation-induced small bowel disease: latest developments and clinical guidance. Ther Adv Chronic Dis. 2014;5:15–29.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Szabo S, Vattay P, Scarbrough E, Folkman J. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med. 1991;91:158s–60s.

    Article  CAS  PubMed  Google Scholar 

  79. Kochhar R, Sriram PV, Sharma SC, et al. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci. 1999;44:973–8.

    Article  CAS  PubMed  Google Scholar 

  80. Gul YA, Prasannan S, Jabar FM, et al. Pharmacotherapy for chronic hemorrhagic radiation proctitis. World J Surg. 2002;26:1499–502.

    Article  PubMed  Google Scholar 

  81. Cavcic J, Turcic J, Martinac P, et al. Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croat Med J. 2000;41:314–8.

    CAS  PubMed  Google Scholar 

  82. Chitapanarux I, Chitapanarux T, Traisathit P, et al. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5:31.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Fuccio L, Guido A. Probiotics supplementation for the prevention of gastrointestinal radiation-induced side effects: the time is now. Am J Gastroenterol. 2013;108:277.

    Article  PubMed  Google Scholar 

  84. Cole AT, Slater K, Sokal M, Hawkey CJ. In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis. Gut. 1993;34:1210–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Seo EH, Kim TO, Kim TG, et al. The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis. Dig Dis Sci. 2011;56:2672–7.

    Article  CAS  PubMed  Google Scholar 

  86. Pikarsky AJ, Belin B, Efron J, et al. Complications following formalin installation in the treatment of radiation induced proctitis. Int J Color Dis. 2000;15:96–9.

    Article  CAS  Google Scholar 

  87. Wedlake LJ, Silia F, Benton B, et al. Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer. 2012;48:2117–24.

    Article  CAS  PubMed  Google Scholar 

  88. Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72:134–43.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey

    Nilufer Kılıc Durankus, Duygu Sezen, Ugur Selek & Yasemin Bolukbasi

  2. Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA

    Ugur Selek & Yasemin Bolukbasi

  3. MD Anderson Radiation Treatment Center, American Hospital, Istanbul, Turkey

    Yasemin Bolukbasi

Authors
  1. Nilufer Kılıc Durankus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duygu Sezen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ugur Selek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasemin Bolukbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nilufer Kılıc Durankus or Yasemin Bolukbasi .

Editor information

Editors and Affiliations

  1. Chair and Professor, Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey

    Gokhan Ozyigit

  2. Chair and Professor, Department of Radiation Oncology, Koc University, Faculty of Medicine, Istanbul, Turkey

    Ugur Selek

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kılıc Durankus, N., Sezen, D., Selek, U., Bolukbasi, Y. (2020). Toxicity Management for Pelvic Tumors in Radiation Oncology. In: Ozyigit, G., Selek, U. (eds) Prevention and Management of Acute and Late Toxicities in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-37798-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-37798-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-37797-7

  • Online ISBN: 978-3-030-37798-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation